Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
AUTOR(ES)
Gökengin, Deniz
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=131012Documentos Relacionados
- Viral Blip Dynamics during Highly Active Antiretroviral Therapy
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
- Dyslipidemia in AIDS patients on highly active antiretroviral therapy
- Highly Active Antiretroviral Therapy and Increased Use of Contraceptives Among HIV-Positive Women During Expanding Access to Antiretroviral Therapy in Mbarara, Uganda
- Osteoarticular complications related to HIV infection and highly active antiretroviral therapy